bromodeoxyuridine has been researched along with sb 202190 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Arteaga, CL; Dumont, N; Koh, Y; Ueda, Y; Wang, S; Yi, JY | 1 |
2 other study(ies) available for bromodeoxyuridine and sb 202190
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Topics: Actins; Activin Receptors, Type I; Adenoviridae; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Blotting, Northern; Breast Neoplasms; Bromodeoxyuridine; Butadienes; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Cell Movement; Chromones; Disease Progression; DNA, Complementary; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Humans; Imidazoles; Immunoblotting; Integrin beta1; Ligands; Luminescent Proteins; Microscopy, Fluorescence; Models, Genetic; Morpholines; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Precipitin Tests; Protein Serine-Threonine Kinases; Pseudopodia; Pyridines; rac1 GTP-Binding Protein; Receptor, ErbB-2; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Retroviridae; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta; Trastuzumab; Wound Healing | 2004 |